Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trastuzumab +/- Tamoxifen in Advanced Breast Cancer
NCT00053339Phase 3Withdrawn
- Sponsor
- Cancer and Leukemia Group B
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of tamoxifen in breast cancer, sponsored by Cancer and Leukemia Group B. Status: withdrawn.
02
Drugs
tamoxifen
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00053339.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00053339.